Trials / Completed
CompletedNCT00505973
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects
An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SCA-136 Administered Orally to Healthy Japanese Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Male
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SCA-136 |
Timeline
- Start date
- 2007-07-01
- Completion
- 2007-10-01
- First posted
- 2007-07-25
- Last updated
- 2007-12-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00505973. Inclusion in this directory is not an endorsement.